Skip to content

Development, Validation, and Assessment of the Diagnostic Accuracy of a Questionnaire for Periodontitis Screening

Sviluppo, Validazione e Determinazione Della Accuratezza Diagnostica di un Questionario Per lo Screening di Parodontite

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07461753
Acronym
Q_ITA
Enrollment
495
Registered
2026-03-10
Start date
2026-04-01
Completion date
2027-01-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases, Periodontitis

Keywords

diagnosis, self-reported questionnaire, validation, sensitivity, specificity

Brief summary

The present study aims at validating the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire \[hereafter referred to as the CDC/AAP\_ITA questionnaire\]. The study also aims to develop a modified version of the CDC/AAP questionnaire, enriched with additional questions, and to evaluate its diagnostic accuracy \[hereafter referred to as the QSIdP questionnaire\]. The study will be conducted at the Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), in collaboration with nine (9) other Italian clinical centers.

Detailed description

The present multicenter cross-sectional clinical study aims at validateing the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire \[hereafter referred to as CDC/AAP\_ITA\]. Furthermore, the study aims at developing a modified version of the CDC/AAP\_ITA questionnaire, enriched with additional questions, and to assess its diagnostic accuracy \[hereafter referred to as QSIdP\]. All procedures included in the study protocol will be conducted in full compliance with the latest version of the Declaration of Helsinki. Participation in the study will require the signing of an informed consent form by each enrolled participant. In addition, the study will adhere to the STARD (Standards for Reporting Diagnostic Accuracy) guidelines. Following development and validation, the CDC/AAP\_ITA questionnaire (consisting of 8 questions) and the QSIdP questionnaire (consisting of 10 questions) will be administered to 495 patients with heterogeneous periodontal conditions recruited from ten Italian university clinical centers and/or public health facilities. Among these, Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), will be the Coordinating Center. Within each center, patients will be enrolled according to specific inclusion criteria (i.e., age ≥18 years, ability to read and understand Italian, willingness to participate in the study) and exclusion criteria (i.e., completely edentulous individuals, subjects who have taken antibiotics within the past 3 months, pregnant women, or individuals with contraindications to periodontal probing). Patient selection will take place during their stay in the waiting area of each participating clinical center, regardless of their chief complaint. Therefore, the questionnaires will be administered to all first-visit patients (and not exclusively to those seeking periodontal assessment). Participants enrolled in the study will be asked to complete both the CDC/AAP\_ITA and QSIdP questionnaires without external assistance. Each questionnaire will be identified by an alphanumeric code composed of the center's identifier and a progressive number. Only the principal investigator at each clinical center will hold the list linking patient names to their corresponding alphanumeric codes, thereby ensuring complete data de-identification. Upon completion of the CDC/AAP\_ITA and QSIdP questionnaires, participants will undergo a full-mouth periodontal clinical examination aimed at recording the following clinical parameters: probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BoP%). Demographic information (age, sex, body mass index), medical history (diabetes, other systemic diseases), and smoking habits will be retrieved from the patient's clinical record. In cases where this information is missing or outdated (more than six months), it will be reconfirmed with the patient. When available, radiographic information will also be integrated into the clinical data. The clinician responsible for recording clinical parameters will then formulate a periodontal diagnosis according to two different classification systems: i) Page & Eke, the reference standard for epidemiological studies; and ii) Tonetti et al. case definition for periodontitis. The association between self-reported measures of periodontal disease (derived from the questionnaires) and clinical diagnosis (derived from the periodontal examination) will be analyzed using logistic regression models adjusted for potential patient-specific confounders.

Interventions

None listed

Sponsors

Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age ≥18 years; * ability to read and understand Italian; * willingness to participate in the study

Exclusion criteria

* completely edentulous individuals; * subjects who have taken antibiotics within the past 3 months; * pregnant women; * individuals with contraindications to periodontal probing

Design outcomes

Primary

MeasureTime frameDescription
Specificitybaseline visitquestionnaire ability to correctly reject healthy patients without a condition
sensitivitybaseline vistquestionnaire ability to correctly detect ill patients out of those who do have the condition

Contacts

CONTACTLeonardo Trombelli, principal investigator
leonardo.trombelli@unife.it+39 0532 688506
CONTACTAnna Simonelli
anna.simonelli@unife.it0532 688506

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026